News und Analysen
Royal Gold Presenting at the 27th Annual CIBC Western Institutional Investor Conference
Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present in the 27th Annual CIBC Western
Travis Perkins: Director/PDMR Shareholding
Independent Bank Group, Inc. Announces Date for Q4 2023 Earnings Call
Independent Bank Group, Inc. (NASDAQ: IBTX), the holding company for Independent Financial, will hold a conference call to discuss fourth quarter and full year 2023 results on Tuesday, January 23
Monro, Inc. to Report Third Quarter Fiscal 2024 Earnings on January 24, 2024
Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, will release its fiscal 2024 third quarter earnings on January 24, 2024. The Company will host a
onsemi to Announce Fourth Quarter and 2023 Annual Financial Results
onsemi (Nasdaq: ON) plans to announce its financial results for the fourth quarter, which ended December 31, 2023, before the market opens on Monday, February 5, 2024.
The company will host a
Acadia Healthcare and Ascension Seton Form Joint Venture to Expand Behavioral Health Services in Austin
Ascension Seton and Acadia Healthcare announced today that the two organizations have formed a joint venture to expand access to behavioral healthcare in Austin, Texas, and surrounding communities
Acadia Healthcare Enters Into a Joint Venture Partnership With Ascension Seton to Expand Behavioral Health Services in Austin, Texas
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture partnership with Ascension Seton, one of the leading, integrated healthcare systems in Austin
Royal Gold Provides Update on its Q4 2023 Stream Segment Sales and Details for Release of Q4 2023 Results
Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that its wholly owned subsidiary, RGLD Gold AG, sold approximately
ICON Issues Financial Guidance for Full Year 2024
ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2024. For the
Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma
Novocure (NASDAQ: NVCR) today announced that the final patient has been enrolled in the global phase 3 TRIDENT clinical trial evaluating the safety and efficacy of initiating Optune Gio® (formerly
Helmerich & Payne, Inc. Announces Fiscal First Quarter 2024 Conference Call and Webcast
In conjunction with Helmerich & Payne, Inc.’s (NYSE: HP) first quarter 2024 earnings release, you are invited to listen to its conference call on Tuesday, January 30, 2024, at 11:00 a.m. (ET) with
Manhattan Associates Announces Date for Reporting Fourth Quarter 2023 Financial Results
Manhattan Associates Inc. (NASDAQ: MANH) today announced it will release its fourth quarter 2023 financial results on Tuesday, January 30, 2024, after the stock market closes. The press release
LivaNova to Wind Down Advanced Circulatory Support Business Unit
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that it will commence immediately with an orderly wind down of the Advanced Circulatory Support (ACS)
Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update
Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial results and operational updates for the quarter and full year ended December 31, 2023. Novocure is a global oncology company
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today launched its “Optimising biotech funding” whitepaper. This provides an overview of the
Aperam announces its financial calendar for 2024
Aperam announces its financial calendar for 2024
Notice of AGM
Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer
Novocure (NASDAQ: NVCR) today announced the appointment of Nicolas Leupin, M.D., Ph.D., MBA to the role of Chief Medical Officer. Dr. Leupin brings a proven track record of leadership and
LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2023 results on Wednesday, February 21, 2024 at 1
Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 9, 2024
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in the J.P. Morgan Healthcare
Diodes Incorporated to Present at the Needham Growth Conference on January 16
Diodes Incorporated (Nasdaq: DIOD), today announced that Brett Whitmire, Chief Financial Officer, Emily Yang, Senior Vice President of Worldwide Sales and Marketing, and Gurmeet Dhaliwal, Director
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 42nd Annual J.P
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that
Acadia Healthcare to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference, January 8-11, 2024, at The Westin St. Francis, San